Mathematical modeling on helper T cells in a tumor immune system

Activation of CD$8^+$ cytotoxic T lymphocytes (CTLs) is naturally regarded as a major antitumor mechanism of the immune system. In contrast, CD$4^+$ T cells are commonly classified as helper T cells (HTCs) on the basis of their roles in providing help to the generation and maintenance of effective CD$8^+$ cytotoxic and memory T cells. In order to get a better insight on the role of HTCs in a tumor immune system, we incorporate the third population of HTCs into a previous two dimensional ordinary differential equations (ODEs) model. Further we introduce the adoptive cellular immunotherapy (ACI) as the treatment to boost the immune system to fight against tumors. Compared tumor cells (TCs) and effector cells (ECs), the recruitment of HTCs changes the dynamics of the system substantially, by the effects through particular parameters, i.e., the activation rate of ECs by HTCs, $p$ (scaled as $\rho$), and the HTCs stimulation rate by the presence of identified tumor antigens, $k_2$ (scaled as $\omega_2$). We describe the stability regions of the interior equilibria $E^*$ (no treatment case) and $E^+$ (treatment case) in the scaled $(\rho,\omega_2)$ parameter space respectively. Both $\rho$ and $\omega_2$ can destabilize $E^*$ and $E^+$ and cause Hopf bifurcations. Our results show that HTCs might play a crucial role in the long term periodic oscillation behaviors of tumor immune system interactions. They also show that TCs may be eradicated from the patient's body under the ACI treatment.

[1]  D. Kirschner,et al.  Modeling immunotherapy of the tumor – immune interaction , 1998, Journal of mathematical biology.

[2]  D. Kirschner,et al.  A mathematical model of tumor-immune evasion and siRNA treatment , 2003 .

[3]  Magda Galach,et al.  DYNAMICS OF THE TUMOR—IMMUNE SYSTEM COMPETITION—THE EFFECT OF TIME DELAY , 2003 .

[4]  Olivier Lantz,et al.  CD4 cells can be more efficient at tumor rejection than CD8 cells. , 2007 .

[5]  Konstantin E. Starkov,et al.  Global dynamics of the Kirschner–Panetta model for the tumor immunotherapy , 2013 .

[6]  Y. Lai,et al.  The Roles of CD4+ T Cells in Tumor Immunity , 2011 .

[7]  Zuzanna Szymańska,et al.  Analysis of Immunotherapy Models in the Context of Cancer Dynamics , 2003 .

[8]  Gail S. K. Wolkowicz,et al.  Bifurcation Analysis of a Chemostat Model with a Distributed Delay , 1996 .

[9]  D. Kirschner,et al.  A Mathematical Model of Gene Therapy for the Treatment of Cancer , 2013 .

[10]  Nicola Bellomo,et al.  A Survey of Models for Tumor-Immune System Dynamics , 1996 .

[11]  Mark A. J. Chaplain,et al.  Oscillations and bistability in the dynamics of cytotoxic reactions mediated by the response of immune cells to solid tumours , 2008, Math. Comput. Model..

[12]  S. Ruan,et al.  Stable periodic oscillations in a two-stage cancer model of tumor and immune system interactions. , 2012, Mathematical biosciences and engineering : MBE.

[13]  Steven A. Rosenberg,et al.  Progress in human tumour immunology and immunotherapy , 2001, Nature.

[14]  D. Earn,et al.  Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models , 2011, Bulletin of mathematical biology.

[15]  L. D. Pillis,et al.  A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth , 2005 .

[16]  M C Mackey,et al.  Periodic chronic myelogenous leukaemia: spectral analysis of blood cell counts and aetiological implications , 1999, British journal of haematology.

[17]  Lloyd J. Old,et al.  A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens , 1998, The Journal of experimental medicine.

[18]  D. Earn,et al.  Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma. , 2010, Journal of theoretical biology.

[19]  R. Noelle,et al.  The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells , 1998, Journal of leukocyte biology.

[20]  Stefano Papa,et al.  NK Cells and Cancer1 , 2007, The Journal of Immunology.

[21]  K. Honda,et al.  Transcriptional Reprogramming of Mature CD4+ T helper Cells generates distinct MHC class II-restricted Cytotoxic T Lymphocytes , 2013, Nature Immunology.

[22]  G. Sell,et al.  The Hopf Bifurcation and Its Applications , 1976 .

[23]  Denise Kirschner,et al.  On the global dynamics of a model for tumor immunotherapy. , 2009, Mathematical biosciences and engineering : MBE.

[24]  P. Bruggen,et al.  Human tumor antigens recognized by T lymphocytes , 1996, The Journal of experimental medicine.

[25]  A. Radunskaya,et al.  Mixed Immunotherapy and Chemotherapy of Tumors: Modeling, Applications and Biological Interpretations , 2022 .

[26]  Bard Ermentrout,et al.  Simulating, analyzing, and animating dynamical systems - a guide to XPPAUT for researchers and students , 2002, Software, environments, tools.

[27]  L A Aguirre,et al.  What can be learned from a chaotic cancer model? , 2013, Journal of theoretical biology.

[28]  Shigui Ruan,et al.  Bifurcation analysis in models of tumor and immune system interactions , 2009 .

[29]  B. Rocha,et al.  A Role for CD40 Expression on CD8+ T Cells in the Generation of CD8+ T Cell Memory , 2002, Science.

[30]  A. Perelson,et al.  Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.

[31]  C. Lowenstein,et al.  The Central Role of CD4+ T Cells in the Antitumor Immune Response , 1998, The Journal of experimental medicine.

[32]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[33]  R. Blasberg,et al.  Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts , 2010, The Journal of experimental medicine.

[34]  A. d’Onofrio A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences , 2005, 1309.3337.

[35]  Ami Radunskaya,et al.  A delay differential equation model for tumor growth , 2003, Journal of mathematical biology.